Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws
- PMID: 16690249
- DOI: 10.1016/j.ijom.2006.03.017
Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws
Abstract
The aim of this study was to investigate the long-term effect of the ceramic beta-tricalcium phosphate (beta-TCP) at different sites of alveolar reconstruction and to evaluate its properties. From 1997 to 2002, beta-TCP was implanted as bone substitute in 152 patients using a standardized study protocol. Main indications were the filling of large mandibular cysts (n=52), secondary and tertiary alveolar cleft grafting (n=38), periodontal defects (n=24) and maxillary sinus floor augmentation (n=16). For defects exceeding 2cm in diameter, beta-TCP was combined with autologous bone taken from the retromolar area, the maxillary tuberosity or the chin region. A radiological, clinical and ultrasonographical examination was carried out 4, 12 and 52 weeks postoperative. In 16 cases, biopsies were taken after 12 months indicating complete bony regeneration. While wound-healing disturbances occurred in 9.2% of cases, partial loss of the bone substitute material was found in 5.9%, while total loss occurred in only 2%. Complete radiological replacement of beta-TCP by autologous bone was found after approximately 12 months, indicating its osteoconductive properties. Because of its versatility, low complication rate and good long-term results, synthetic, pure-phase beta-TCP is a suitable material for the filling of bone defects in the alveolar region.
Similar articles
-
Micro-structured calcium phosphate ceramic for donor site repair after harvesting chin bone for grafting alveolar clefts in children.J Craniomaxillofac Surg. 2014 Jul;42(5):460-8. doi: 10.1016/j.jcms.2013.05.042. Epub 2013 Jul 10. J Craniomaxillofac Surg. 2014. PMID: 23850157 Clinical Trial.
-
Early secondary closure of alveolar clefts with mandibular symphyseal bone grafts and beta-tri calcium phosphate (beta-TCP).Int J Oral Maxillofac Surg. 2010 May;39(5):424-9. doi: 10.1016/j.ijom.2010.02.004. Epub 2010 Mar 29. Int J Oral Maxillofac Surg. 2010. PMID: 20303237
-
Micro-structured Beta-Tricalcium Phosphate for Repair of the Alveolar Cleft in Cleft Lip and Palate Patients: A Pilot Study.Cleft Palate Craniofac J. 2015 May;52(3):336-40. doi: 10.1597/13-260. Epub 2014 Jun 11. Cleft Palate Craniofac J. 2015. PMID: 24919123
-
Alternatives to Autologous Bone Graft in Alveolar Cleft Reconstruction: The State of Alveolar Tissue Engineering.J Craniofac Surg. 2018 May;29(3):584-593. doi: 10.1097/SCS.0000000000004300. J Craniofac Surg. 2018. PMID: 29461365 Review.
-
Filling bone defects with β-TCP in maxillofacial surgery: A review.Morphologie. 2017 Sep;101(334):113-119. doi: 10.1016/j.morpho.2017.05.002. Epub 2017 May 29. Morphologie. 2017. PMID: 28571762 Review.
Cited by
-
Scaffolds for Dentin-Pulp Complex Regeneration.Medicina (Kaunas). 2023 Dec 20;60(1):7. doi: 10.3390/medicina60010007. Medicina (Kaunas). 2023. PMID: 38276040 Free PMC article. Review.
-
Morphology, Cytotoxicity, and Antimicrobial Activity of Electrospun Polycaprolactone Biomembranes with Gentamicin and Nano-Hydroxyapatite.Membranes (Basel). 2023 Dec 28;14(1):10. doi: 10.3390/membranes14010010. Membranes (Basel). 2023. PMID: 38248701 Free PMC article.
-
Nanoscaled biphasic calcium phosphate modulates osteogenesis and attenuates LPS-induced inflammation.Front Bioeng Biotechnol. 2023 Nov 29;11:1236429. doi: 10.3389/fbioe.2023.1236429. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38094898 Free PMC article.
-
Artificial Bone Graft Substitutes for Curettage of Benign and Low-Grade Malignant Bone Tumors: Clinical and Radiological Experience with Cerasorb.Indian J Orthop. 2023 Jun 22;57(9):1409-1414. doi: 10.1007/s43465-023-00919-1. eCollection 2023 Sep. Indian J Orthop. 2023. PMID: 37609019 Free PMC article.
-
Clindamycin-Loaded Nanosized Calcium Phosphates Powders as a Carrier of Active Substances.Nanomaterials (Basel). 2023 Apr 25;13(9):1469. doi: 10.3390/nano13091469. Nanomaterials (Basel). 2023. PMID: 37177013 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
